Zota Healthcare Quarterly Results for Trading Insights
In Mar 2026, Zota Healthcare (ZOTA) reported revenue ₹166 Cr and net profit ₹-15 Cr — revenue +69.4% YoY. Browse ZOTA balance sheet details for revenue, profit, balance sheet and cash flow data.
ZOTA Quarterly Results — Revenue, Profit & EPS Highlights
Zota Healthcare latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore Zota Healthcare stock price data download to track price trends across different timeframes.
- Revenue of ₹166 Cr in Mar 2026 (+26.7% vs Sept 2025, +69.4% vs Mar 2025)
- Net Profit of ₹-15 Cr in Mar 2026 (+6.2% vs Sept 2025, -15.4% vs Mar 2025)
- EBITDA of ₹6 Cr in Mar 2026 (-25.0% vs Sept 2025)
- Operating Margin of 2.0% in Mar 2026 (-3.0pp vs Sept 2025)
- Earnings Per Share of ₹-4.13 in Mar 2026 (+21.5% vs Sept 2025)
Zota Healthcare Quarterly Results — Revenue, EBITDA, Net Profit & EPS
ZOTA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 166 | 131 | 98 | 105 | 145 | 26.7% | 69.4% |
| Net Profit (₹ Cr) | -15 | -16 | -13 | -14 | -30 | - | - |
| EBITDA (₹ Cr) | 6 | 8 | 4 | 5 | 1 | - | - |
| EPS (₹) | -4.13 | -5.26 | -4.57 | -4.92 | -9.44 | - | - |
| Operating Margin (%) | 2.0% | 5.0% | 3.0% | 4.0% | 0.0% | - | - |
ZOTA Share Price Trend — 1-Year Movement Across Quarterly Results
Zota Healthcare 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit ZOTA share price screener.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
ZOTA vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Zota Healthcare latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹454,122.13 Cr | 1904.8 | 15,018 | 2,710 | +1.0% | +11.8% | 18.0% | 168.6 |
|
Divis Laboratories
Mar 2026 |
₹174,081.02 Cr | 6757.0 | 2,986 | 751 | +4.4% | +11.8% | 25.2% | 238.7 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹161,380.94 Cr | 4768.3 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 414.3 |
|
Cipla
Mar 2026 |
₹117,800.00 Cr | 1458.2 | 6,612 | 543 | -14.3% | -4.0% | 8.2% | 212.3 |
|
Dr Reddys Laborator…
Mar 2026 |
₹114,691.88 Cr | 1374.1 | 7,996 | 221 | -12.5% | -11.5% | 2.8% | 518.5 |
All amounts in ₹ Crores